Patent · US Active

Delayed release rasagiline citrate formulation

US8080584B2 · kind B2 · utility

11Cited by

28References

41Claims

0Family size

Assignee

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · IL

Inventors

Muhammad Safadi · Nazareth, IL
Daniella Licht · Givat Shmuel, IL
Rachel Cohen · Hadera, IL
Anton Frenkel · Netanya, IL
Marina Zholkovsky · Bat Yam, IL

Key dates

Filing date	Jun 9, 2009
Grant date	Dec 20, 2011
Priority date	—
Expiry date	Sep 12, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2602/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.